The N-recognin UBR4 of the N-end rule pathway is targeted to and required for the biogenesis of the early endosome

Author:

Kim Sung Tae12ORCID,Lee Yoon Jee1,Tasaki Takafumi3,Mun Suran1,Hwang Joonsung4,Kang Min Jueng5,Ganipisetti Srinivasrao1,Yi Eugene C.5,Kim Bo Yeon4,Kwon Yong Tae16ORCID

Affiliation:

1. Protein Metabolism Medical Research Center and Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul, 03080, Republic of Korea

2. Center for Pharmacogenetics and Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, 15261, USA

3. Medical Research Institute, Kanazawa Medical University, Ishikawa, 920-0293, Japan

4. World Class Institute, Anticancer Agents Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang, Cheongwon, 28116, Republic of Korea

5. Department of Molecular Medicine and Biopharmaceutical Sciences, School of Convergence Science and Technology and College of Medicine or College of Pharmacy, Seoul National University, Seoul, Seoul, 03080, Republic of Korea

6. Ischemic/Hypoxic Disease Institute, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea

Abstract

The N-end rule pathway is a proteolytic system in which single N-terminal residues of proteins act as N-degrons. These degrons are recognized by N-recognins, facilitating substrate degradation via the ubiquitin (Ub) proteasome system (UPS) or autophagy. We have previously identified a set of N-recognins (UBR1, UBR2, UBR4/p600, and UBR5/EDD) that bind N-degrons through their UBR boxes to promote proteolysis by the proteasome. Here, we show that the 570 kDa N-recognin UBR4 is associated with maturing endosomes through the interaction with Ca2+-bound calmodulin. The endosomal recruitment of UBR4 is essential for the biogenesis of early endosomes (EEs) and endosome-related processes such as the trafficking of endocytosed protein cargoes and degradation of extracellular cargoes by endosomal hydrolases. In mouse embryos, UBR4 marks and plays a role in the endosome-lysosome pathway that mediates the heterophagic proteolysis of endocytosed maternal proteins into amino acids. By screening 9,591 drugs through DrugBank database, we identify picolinic acid as a putative ligand to UBR4, which inhibits the biogenesis of EEs. Our results suggest that UBR4 is an essential modulator in the endosome-lysosome system.

Funder

National Research Foundation of Korea

Ministry of Science ICT and Future Planning

National Research Council of Science and Technology

Kanazawa Medical University

Japan Society for the Promotion of Science

Seoul National University

Brain Korea 21 PLUS

Seoul National University Hospital

Korea Research Institute of Bioscience and Biotechnology

Publisher

The Company of Biologists

Subject

Cell Biology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3